EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, In Vitro, and In Silico Evaluation of Isoxazole–Isoxazoline Conjugates as Potential Antimicrobial Agents

Aziz Arzine, Soumia Ait Assou, Fatima Zahra Guerguer, Khalid Boujdi, Yassine Rhazi, Mohammed Chalkha iD, Asmae Nakkabi, Mohamed Akhazzane, Joel T Mague, Samir Chtita, Mohammed El Hassouni, Mohamed El Yazidi

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Aziz Arzine und 11 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Laboratory of Organometallic, Molecular Materials and Environment, Faculty of Sciences Dhar EL Mahraz, Sidi Mohamed Ben Abdellah Universi…. Hauptthemen laut MEDLINE: Isoxazoles, Drug Design, Anti-Bacterial Agents, Antifungal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new series of hybrid compounds ( 5a–h ) incorporating both isoxazole and isoxazoline scaffolds has been successfully synthesized, characterized, and assessed for their antimicrobial propriety. The newly synthesized conjugates were characterized through various spectroscopic methods, including FT‐IR, 1D and 2D NMR, along with mass spectrometry. The conjugate compounds were subsequently evaluated for their antimicrobial activity against the some pathogenic following bacterial strains. Compounds ( 5a–d ) and ( 5h ) demonstrated notable activity in vitro against Escherichia coli , exhibiting an inhibition zone diameter (IZD) of 16 ± 0.74 mm and an inhibition rate of 80%. This activity is comparable to that of ampicillin, which was selected as a standard for comparison. Compound ( 5c ) exhibited notable efficacy against Bacillus subtilis , with an inhibition rate of 50%. Concurrently, compound ( 5a ) was distinguished by its noteworthy antifungal properties, exhibiting an IZD of 21 ± 0.50 mm (77% inhibition), which is comparable to the standard reference amphotericin B. The minimal inhibitory concentration (MIC) tests indicated that the compound ( 5h ) exhibited notable efficacy against E. coli , B. subtilis , and Candida albicans , with MICs of 10, 10, and 60 µg/mL, respectively, approaching the values of the established standards of amphotericin B and ampicillin. Molecular docking analysis revealed favorable binding affinities of compounds ( 5a–h ) against E. coli , B. subtilis , and C. albicans , outperforming conventional antibiotics. Molecular dynamics simulations were carried out on ( 5h ), the most effective antibacterial and antifungal compound. ADME‐Tox evaluation showed high intestinal absorption, especially for ( 5d ) and ( 5h ) (100%), blood retention, and a favorable safety profile with efficient elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoxazolesDrug DesignAnti-Bacterial AgentsAntifungal AgentsMicrobial Sensitivity TestsBacillus subtilisEscherichia coliStructure-Activity RelationshipMolecular Docking SimulationCandida albicansMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

compounds hybridsin vitro antimicrobial activityin‐silico studiesisoxazoleisoxazoline

Substanzen

IsoxazolesAnti-Bacterial AgentsAntifungal Agents

Autor:innen und Institutionen

  • Engineering Laboratory of Organometallic, Molecular Materials and Environment, Faculty of Sciences Dhar EL Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
  • Biotechnology, Environment, Agri-Food and Health Laboratory, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
  • Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II, University of Casablanca, Casablanca, Morocco.
  • Faculty of Sciences and Technologies Mohammedia, University Hassan 2, URAC 22 FSTM University Hassan II-Casablanca, Mohammedia, Morocco.
  • Laboratory of Materials Engineering for the Environment and Natural Resources, Faculty of Sciences and Techniques, University of Moulay Ismail of Meknès, Errachidia, Morocco.
  • Cité de l'innovation, Université Sidi Mohamed Ben Abdellah, Route Immouzer, Fez, Morocco.

ORCID-Profile: Mohammed Chalkha

Zitieren

APA

Arzine, A., Ait Assou, S., Guerguer, F. Z., Boujdi, K., Rhazi, Y., Chalkha, M., Nakkabi, A., Akhazzane, M., Mague, J. T., Chtita, S., Hassouni, M. E., & El Yazidi, M. (2025). Design, Synthesis, In Vitro, and In Silico Evaluation of Isoxazole–Isoxazoline Conjugates as Potential Antimicrobial Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500600

Vancouver

Arzine A, Ait Assou S, Guerguer FZ, Boujdi K, Rhazi Y, Chalkha M, et al. Design, Synthesis, In Vitro, and In Silico Evaluation of Isoxazole–Isoxazoline Conjugates as Potential Antimicrobial Agents. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500600

BibTeX
@article{Arzine2025,
  author = {Arzine, Aziz and Ait Assou, Soumia and Guerguer, Fatima Zahra and Boujdi, Khalid and Rhazi, Yassine and Chalkha, Mohammed and Nakkabi, Asmae and Akhazzane, Mohamed and Mague, Joel T and Chtita, Samir and Hassouni, Mohammed El and El Yazidi, Mohamed},
  title = {Design, Synthesis, In Vitro, and In Silico Evaluation of Isoxazole–Isoxazoline Conjugates as Potential Antimicrobial Agents},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500600}
}
Kostenlos starten →